Breast Cancer Research and Treatment

, Volume 90, Issue 1, pp 15–23 | Cite as

Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis

  • Claudia A. Krusche
  • Pia Wülfing
  • Christian Kersting
  • Anne Vloet
  • Werner Böcker
  • Ludwig Kiesel
  • Henning M. Beier
  • Joachim Alfer
Report

Summary

Impaired histone acetylation was recognized to be involved in carcinogenesis. Furthermore, histone deacetylase (HDAC) inhibitors induce differentiation of breast cancer cells and inhibit tumour growth. These results prompted us to study HDAC-1 and -3 expression in breast tumours to establish their potential therapeutic and prognostic significance.

HDAC-1 und HDAC-3 protein expression was analyzed immunohistochemically on a tissue microarray (TMA) containing 600 core biopsies from 200 patients. HDAC-1 and -3 expression was correlated to steroid hormone receptor-, Her2/neu- and proliferation status of tumours as well as to overall and disease free survival.

Moderate or strong nuclear immunoreactivity for HDAC-1 was observed in 39.8% and for HDAC-3 in 43.9% of breast carcinomas. HDAC-1 and -3 expression correlated significantly with oestrogen and progesterone receptor expression (both p< 0.001). HDAC-1 expression predicted significantly better disease free survival (DFS: p=0.044), in particular, in patients with small tumours of all differentiation types (DFS: p=0.016). Multivariate analysis demonstrated that HDAC-1 is an independent prognostic marker.

Our data suggest that evaluation of HDAC-1 protein expression enables a more precise assessment of the prognosis of breast cancer patients. Thus, HDAC-1 expression analysis might be clinically useful to facilitate an individual, risk-directed, adjuvant systemic therapy in breast cancer patients.

Keywords

breast cancer cell differentiation histone deacetylases prognostic marker survival 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Momparler, RL 2003Cancer epigeneticsOncogene2264796483PubMedGoogle Scholar
  2. Thiagalingam, S, Cheng, KH, Lee, H, Mineva, N, Thiagalingam, A, Ponte, JF 2003Histone deacetylases: unique players in shaping the epigenetic histone codeAnn NY Acad Sci98384100CrossRefPubMedGoogle Scholar
  3. Yan, L, Yang, X, Davidson, NE 2001Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancerJ Mammary Gland Biol Neoplasia6183192PubMedGoogle Scholar
  4. Cress, WD, Seto, E 2000Histone deacetylases, transcriptional control, and cancerJ Cell Physiol184116PubMedGoogle Scholar
  5. Lagger, G, Doetzlhofer, A, Schuettengruber, B, Haidweg, E, Simboeck, E, Tischler, J, Chiocca, S, Suske, G, Rotheneder, H, Wintersberger, E, Seiser, C 2003The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 geneMol Cell Biol2326692679PubMedGoogle Scholar
  6. Lagger, G, O’Carroll, D, Rembold, M, Khier, H, Schuettengruber, B, Hauser, C, Brunmeir, R, Jenuwein, T, Seiser, C 2002Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repressionEMBO J2126722681PubMedGoogle Scholar
  7. Davis, T, Kennedy, C, Chiew, YE, Clarke, CL, Fazio, A 2000Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cellsClin Cancer Res643344342PubMedGoogle Scholar
  8. Keen, JC, Yan, L, Mack, KM, Pettit, C, Smith, D, Sharma, D, Davidson, NE 2003A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza-2′-deoxycytidineBreast Cancer Res Treat81177186PubMedGoogle Scholar
  9. Jang, ER, Lim, SJ, Lee, ES, Jeong, G, Kim, TY, Bang, YJ, Lee, JS 2004The histone deacetylase inhibitor trichostatin A sensitizes oestrogen receptor α-negative breast cancer cells to tamoxifenOncogene2317241736PubMedGoogle Scholar
  10. Fuino, L, Bali, P, Wittmann, S, Donapaty, S, Guo, F, Yamaguchi, H, Wang, HG, Atadja, P, Bhalla, K 2003Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone BMol Cancer Ther2971984PubMedGoogle Scholar
  11. Vigushin, DM, Ali, S, Pace, PE, Mirsaidi, N, Ito, K, Adcock, I, Coombes, RC 2001Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivoClin Cancer Res7971976PubMedGoogle Scholar
  12. Kuperwasser, C, Pinkas, J, Hurlbut, GB, Naber, SP, Jerry, DJ 2000Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatmentCancer Res6027232729PubMedGoogle Scholar
  13. Zhang, HS, Dean, DC 2001Rb-mediated chromatin structure regulation and transcriptional repressionOncogene2031343138PubMedGoogle Scholar
  14. Glaser, KB, Li, J, Staver, MJ, Wie, RQ, Albert, DH, Davidsen, SK 2003Role of class I and class II histone deacetylases in carcinoma cells using siRNABiochem Biophy Res Commun310529536Google Scholar
  15. Guenther, MG, Barak, O, Lazar, MA 2001The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3Mol Cell Biol2160916101PubMedGoogle Scholar
  16. Yarden, RI, Brody, LC 1999BRCA1 interacts with components of the histone deacetylase complexProc Natl Acad Sci USA9649834988PubMedGoogle Scholar
  17. Kononen, J, Bubendorf, L, Kallioniemi, A, Barlund, M, Schraml, P, Leighton, S, Torhorst, J, Milhatsch, MJ, Sauter, G, Kallioniemi, OP 1998Tissue microarrays for high-throughput molecular profiling of tumor specimensNat Med4844847PubMedGoogle Scholar
  18. Wülfing, P, Diallo, R, Müller, C, Wülfing, C, Poremba, C, Heinecke, A, Rody, A, Greb, RR, Böcker, W, Kiesel, L 2003Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysisJ Cancer Res Clin Oncol129375382PubMedGoogle Scholar
  19. Reiner, A, Neumeister, B, Spona, J, Reiner, G, Schemper, M, Jakesz, R 1990Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancerCancer Res5010571061Google Scholar
  20. Poremba, C, Boecker, W, Willenbring, H, Schafer, KL, Otterbach, F, Burger, H, Diallo, R, Dockhorn-Dworniczak, B 1998Telomerase activity in human proliferative breast lesionsInt J Oncol12641648PubMedGoogle Scholar
  21. Altman DG: Chi square test for trend. In: Practical Statistics for Medical Research. Chapman & Hall, London, 1995, pp 261–265.Google Scholar
  22. Kouraklis, G, Theocharis, S 2002Histone deacetylase inhibitors and anticancer therapyCurr Med Chem Anti-Canc Agents2477484Google Scholar
  23. Goldhirsch, A, Glick, JH, Gelber, RD, Coates, AS, Senn, HJ 2001Meeting highlights: international consensus panel on the treatment of primary breast cancerJ Clin Oncol1938173827PubMedGoogle Scholar
  24. Hoos, A, Urist, MJ, Stojadinovic, A, Mastorides, S, Dudas, ME, Leung, DHJ, Kuo, D, Brennan, MF, Lewis, JL, Cordon-Cardo, C 2001Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumoursAm J Pathol15812451251PubMedGoogle Scholar
  25. van’t Veer, LJ, Dai, H, Vijver, MJ, He, YD, Hart, AAM, Mao, M, Peterse, HL, Kooy, K, Marton, MJ, Witteveen, AT, Schreiber, GJ, Kerkhoven, RM, Roberts, C, Linsley, PS, Bernards, R, Friend, SH 2002Gene expression profiling predicts clinical outcome of breast cancerNature415530536CrossRefPubMedGoogle Scholar
  26. Santini, D, Ceccarelli, C, Taffurelli, M, Pileri, S, Marrano, D 1996Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expressionJ Pathol179386391PubMedGoogle Scholar
  27. Clarke, RB 2003Steroid receptors and proliferation in human breastSteroids68789794PubMedGoogle Scholar
  28. Kawai, H, Li, H, Avraham, S, Jiang, S, Avraham, HK 2003Over expression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of oestrogen receptor alphaInt J Cancer107353358PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Claudia A. Krusche
    • 1
    • 5
  • Pia Wülfing
    • 2
  • Christian Kersting
    • 3
  • Anne Vloet
    • 1
  • Werner Böcker
    • 3
  • Ludwig Kiesel
    • 2
  • Henning M. Beier
    • 1
  • Joachim Alfer
    • 4
  1. 1.Department of Anatomy and Reproductive BiologyRWTH University of AachenGermany
  2. 2.Department of Obstetrics and GynecologyGermany
  3. 3.Gerhard-Domagk-Institute of PathologyUniversity of MünsterGermany
  4. 4.Department of PathologyRWTH University of AachenGermany
  5. 5.Department of Anatomy and Reproductive BiologyAachenGermany

Personalised recommendations